Interpersonal Functioning & Social Connectedness

This report summarises what Blossom’s database shows about psychedelics and the social side of life: empathy, trust, warmth, loneliness and the much-discussed idea of "connectedness". It is worth being clear at the outset what kind of page this is. It is not a condition page and not a treatment. It is about a domain of effect, how these drugs change the way people relate to others, and about a popular theory that this social effect is how they heal.

A note before the evidence

This page is a research summary, not medical advice, and nothing here is a recommendation to take psychedelics. Much of the evidence below describes acute effects in healthy volunteers under laboratory conditions, or self-reports gathered in retreats and surveys. A feeling of warmth or connection under a drug is a real experience, but it is not, by itself, evidence of lasting change in anyone’s relationships or mental health.

The solid core: MDMA and acute prosociality

The strongest, cleanest evidence in this whole topic is that MDMA acutely increases empathy, trust and social warmth. What makes it convincing is the comparison group. Researchers test MDMA against a stimulant, methamphetamine, so that ordinary stimulant sociability cannot be mistaken for something deeper. On that test MDMA stands out: it raises global trust, in one’s wider community, where methamphetamine does not[1]J Psychopharmacol (2025), MDMA (not methamphetamine) raises global trust (t(14)=-2.58, p=0.022) in healthy volunteers, increases positive responses to social feedback[2]J Psychopharmacol (2024), MDMA (1.5 mg/kg) enhances positive affective responses to social feedback vs placebo and methamphetamine (N=36 crossover), and enhances how the brain processes emotional faces[3]Eur J Neurosci (2024), MDMA (not methamphetamine) enhances early neural face processing (N170) for happy and angry faces. A biological mechanism is identified rather than assumed: MDMA powerfully activates the oxytocin system, and the oxytocin release tracks its prosocial effects[4]Lancet Diabetes Endocrinol (2023), MDMA strongly raises plasma oxytocin and the rise tracks its subjective prosocial/empathic effects (provocation study).

This is genuinely strong work, and it is the legitimate heart of the topic. It is also, importantly, acute. These studies measure what happens in the hours after a dose, usually in healthy volunteers. They establish, convincingly, that MDMA produces a prosocial state. They do not, on their own, establish that this state translates into durable improvement in someone’s relationships or social functioning, and it is important not to let the strength of the acute finding stand in for an outcome it does not measure.

Classic psychedelics: emotional, not cognitive, empathy

For the classic psychedelics, the careful claim is narrower than the popular one, and the difference matters. A meta-analysis found that classic psychedelics raise emotional empathy, the capacity to feel with others, but not cognitive empathy, the capacity to accurately read them[5]Scientific Reports (2024), meta-analysis: classic psychedelics enhance emotional empathy (explicit and implicit) but NOT cognitive empathy. The best clinical demonstration, a two-week increase in emotional empathy in depressed patients after psilocybin[6]Molecular Psychiatry (2024), single-dose psilocybin raised explicit emotional empathy for at least two weeks in 51 depressed patients (RCT), fits the same pattern. So these drugs appear to increase warmth and emotional openness, not social skill or understanding. The everyday language of "connection" tends to blur that line, implying an improvement in relating that the data do not show.

The trouble with "connectedness"

"Connectedness" has become the field’s favourite explanation, and that is both its strength and its weakness. The strength is that it captures something real and widely reported. The weakness is that it is fuzzy, self-reported, and at risk of circularity: it is typically measured by questionnaires in the same people who also report feeling better, so "felt more connected" and "felt better" can be two descriptions of one thing rather than a cause and its effect. When a single self-reported feeling is asked to explain depression relief, addiction recovery and spiritual insight all at once, it has been stretched past the point of usefulness, a tendency captured almost literally by a proposal to rename MDMA a "connectogen"[7]J Psychopharmacol (2024), proposes renaming MDMA a "connectogen" — an example of stretching "connection" to cover all of its effects encompassing connection to self, others, the body, the world and the spiritual.

The mediator studies are where this matters most. It is striking that, in trauma therapy, changes in self-compassion fully mediated MDMA’s effect on symptoms[8]Eur J Psychotraumatol (2025), self-compassion change fully mediated MDMA-AT effects on PTSD and depression (N=82, self-report mediator), and that MDMA-assisted therapy improved interpersonal self-capacities[9]preprint (2024), MDMA-AT improved interpersonal self-capacities (alexithymia, interpersonal conflict, abandonment concerns) vs placebo in Phase 3 (N=90). These findings are consistent with the idea that connection is the active ingredient. But they are statistical relationships among self-report measures within a trial, not proof that becoming more connected causes lasting interpersonal change. They raise the hypothesis; they do not confirm it.

What we still do not know

The biggest gap is durable, behavioural, real-world evidence. Almost everything solid is acute and self-reported. There is very little controlled work showing that psychedelics produce lasting, observer-visible improvement in real relationships or social networks. The hints that exist cut in an interesting direction: in older adults, it was the relational experience around the session, not the strength of the drug effect, that predicted later well-being[10]Am J Geriatr Psychiatry (2024), in older adults relational experiences (r=0.37), not the acute drug effect, predicted well-being gains (prospective cohort), suggesting the human context may do much of the work. And where social effects have been tested against a placebo with proper statistics, they can evaporate: psilocybin microdosing did not reliably improve social cognition once multiple comparisons were corrected for[11]Neuropharmacology (2026), psilocybin microdosing social-cognition signals did not survive correction for multiple comparisons (two double-blind RCTs).

There are also promising signals in specific groups that belong on other pages: autistic adults, for instance, self-report reduced social anxiety and more social engagement after psychedelic experiences[12]Psychopharmacology (2024), autistic adults self-attributed reduced social anxiety (78%) and more social engagement (70%) to a psychedelic experience (survey, n=233), though that evidence is non-experimental and self-selected. Even ketamine shows an unexpected "entactogen-like" social-pleasure signal[13]Am J Psychiatry (2024), ketamine (0.5 mg/kg) raised social pleasure for a week in TRD and helping behaviour in rats (reverse-translational). These are worth following, but they are early, and none of them yet closes the gap between a felt sense of connection and a measured change in a person’s social life.

Reading this honestly

So how should you read the social story? As a real domain of effect wrapped in a slightly inflated idea. The acute findings are solid, especially for MDMA: these drugs really do, in the moment, increase empathy, trust and warmth, and for MDMA that effect is specific and biologically grounded. Classic psychedelics genuinely raise emotional empathy. That much is well earned. But "connectedness" as a healing mechanism is still a hypothesis, not a result: it is measured by self-report, it is hard to separate from feeling better in general, it has been stretched to cover almost everything, and it lacks the durable, real-world, behavioural evidence that would turn it from an appealing story into an established fact. The most useful thing this literature offers an honest reader is the discipline to hold two true statements at once: that psychedelics produce a powerful and genuine social effect, and that we do not yet know whether feeling connected makes people’s actual relationships and lives lastingly better.